1-5 of 5
risk assessment
Close
Sort by
Journal Articles

Improvements in diagnosis and risk assessment of primary and secondary antiphospholipid syndrome

Michelle Petri
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 415–420.
https://doi.org/10.1182/hematology.2019000046
Published: 2019
Journal Articles

Integrating patient-centered factors in the risk assessment of MDS

Rena J. Buckstein
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 373–380.
https://doi.org/10.1182/hematology.2019000041
Published: 2019
Journal Articles

Classification and risk assessment in AML: integrating cytogenetics and molecular profiling

Matahi Moarii, Elli Papaemmanuil
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 37–44.
https://doi.org/10.1182/asheducation-2017.1.37
Published: 2017
Journal Articles

MRD in AML: does it already guide therapy decision-making?

Gert Ossenkoppele, Gerrit Jan Schuurhuis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 356–365.
https://doi.org/10.1182/asheducation-2016.1.356
Published: 2016
Journal Articles

Phase 4 research: what happens when the rubber meets the road?

Mark Crowther
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 15–18.
https://doi.org/10.1182/asheducation-2013.1.15
Published: 2013